Ponta Wealth Partners, LLC

Position in ABBV — AbbVie Inc.

CIK 2107740 WINTER PARK, FL

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$859,350

+$155,770 QoQ

Shares Held

3,415

+5.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#2,690

of 4,153 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ponta Wealth Partners, LLC holds $5,898,519 across 6 Drug Manufacturers - General names. ABBV ranks #3 (14.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,959	$2,349,683
2	JNJ	Johnson & Johnson	3,503	$889,656
3	ABBV	AbbVie Inc. This page	3,415	$859,350
4	GILD	Gilead Sciences, Inc.	6,022	$760,819
5	MRK	Merck & Co., Inc.	5,816	$747,356
6	NVS	Novartis AG	1,861	$291,655

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$859,350	3,415	+5.6%	Shares	Sole	2026-08-12
2026-03-31	$703,580	3,235	+2.3%	Shares	Sole	2026-05-11
2025-12-31	$722,713	3,163	—	Shares	Sole	2026-02-03
No filing history on record for this holder in this stock.